Sue Fox

641 total citations
21 papers, 490 citations indexed

About

Sue Fox is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Organic Chemistry. According to data from OpenAlex, Sue Fox has authored 21 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 8 papers in Hematology and 4 papers in Organic Chemistry. Recurrent topics in Sue Fox's work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (7 papers) and Adenosine and Purinergic Signaling (4 papers). Sue Fox is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (7 papers) and Adenosine and Purinergic Signaling (4 papers). Sue Fox collaborates with scholars based in United Kingdom, United States and Germany. Sue Fox's co-authors include Stan Heptinstall, Jane May, M. Behan, Ann E. White, Liancheng Zhao, David Iyú, Natalia Dovlatova, Catherine Kwik‐Uribe, Andrew J. Johnson and Dan Hartman and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Thrombosis and Haemostasis and Cell Calcium.

In The Last Decade

Sue Fox

21 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Fox United Kingdom 14 283 148 103 91 70 21 490
C.M. Ingerman-Wojenski United States 9 202 0.7× 118 0.8× 135 1.3× 56 0.6× 105 1.5× 12 578
Sonia Varghese United States 7 98 0.3× 82 0.6× 32 0.3× 31 0.3× 35 0.5× 8 399
Tobias Riexinger Germany 5 290 1.0× 56 0.4× 31 0.3× 45 0.5× 30 0.4× 8 569
Olfa Helal France 13 268 0.9× 23 0.2× 29 0.3× 85 0.9× 189 2.7× 17 876
H. Strobach Germany 13 145 0.5× 41 0.3× 86 0.8× 20 0.2× 73 1.0× 31 568
Elisabetta Trifirò Italy 8 141 0.5× 56 0.4× 101 1.0× 36 0.4× 47 0.7× 9 307
Jennifer Yeung United States 7 117 0.4× 76 0.5× 63 0.6× 48 0.5× 28 0.4× 7 293
Evandro M. Neto‐Neves Brazil 16 211 0.7× 41 0.3× 16 0.2× 101 1.1× 37 0.5× 30 527
Valeria Zuliani Italy 10 111 0.4× 22 0.1× 100 1.0× 11 0.1× 67 1.0× 17 376
Marian Tomasiak Poland 13 103 0.4× 99 0.7× 62 0.6× 27 0.3× 35 0.5× 25 376

Countries citing papers authored by Sue Fox

Since Specialization
Citations

This map shows the geographic impact of Sue Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Fox more than expected).

Fields of papers citing papers by Sue Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Fox. The network helps show where Sue Fox may publish in the future.

Co-authorship network of co-authors of Sue Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Fox. A scholar is included among the top collaborators of Sue Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Fox. Sue Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbas, Zainab Sabri, M.L. Latif, Natalia Dovlatova, et al.. (2017). UDP-sugars activate P2Y 14 receptors to mediate vasoconstriction of the porcine coronary artery. Vascular Pharmacology. 103-105. 36–46. 19 indexed citations
2.
Dunning, Mark, et al.. (2017). A Remote Assay for Measuring Canine Platelet Activation and the Inhibitory Effects of Antiplatelet Agents. Journal of Veterinary Internal Medicine. 32(1). 119–127. 5 indexed citations
3.
Bath, Philip M., Jane May, Katie Flaherty, et al.. (2017). Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack. Stroke Research and Treatment. 2017. 1–13. 9 indexed citations
4.
Panteleev, Mikhail A., Anastasia N. Sveshnikova, Aleksey V. Belyaev, et al.. (2014). Systems Biology and Systems Pharmacology of Thrombosis. Mathematical Modelling of Natural Phenomena. 9(6). 4–16. 7 indexed citations
5.
Fox, Sue, Jane May, Andrew J. Johnson, et al.. (2012). Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12antagonist bothin-vitroandex-vivoin human volunteers. Platelets. 24(5). 392–400. 26 indexed citations
6.
Iyú, David, et al.. (2011). P2Y12and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP. Platelets. 22(7). 504–515. 25 indexed citations
7.
White, Ann E., et al.. (2010). Mode of action of P2Y12 antagonists as inhibitors of platelet function. Thrombosis and Haemostasis. 105(1). 96–106. 22 indexed citations
8.
Fox, Sue, Jane May, Ajay M. Shah, U. Neubert, & Stan Heptinstall. (2009). Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets. 20(4). 250–259. 35 indexed citations
9.
10.
Heptinstall, Stan, David Iyú, Ann E. White, et al.. (2008). DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8). 605–613. 55 indexed citations
11.
Glenn, Jacqueline R., et al.. (2008). Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1). 59–69. 6 indexed citations
12.
Heptinstall, Stan, Jane May, Sue Fox, Catherine Kwik‐Uribe, & Liancheng Zhao. (2006). Cocoa Flavanols and Platelet and Leukocyte Function: Recent In Vitro and Ex Vivo Studies in Healthy Adults. Journal of Cardiovascular Pharmacology. 47(Supplement 2). S197–S205. 67 indexed citations
13.
Zhao, Liancheng, Sally Fletcher, Jo Leonardi‐Bee, et al.. (2005). Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. Thrombosis and Haemostasis. 93(3). 527–534. 17 indexed citations
14.
Fox, Sue, et al.. (2004). Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets. 15(2). 85–93. 35 indexed citations
16.
Zhao, Liancheng, Philip M. Bath, Sue Fox, et al.. (2003). The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current Medical Research and Opinion. 19(3). 178–186. 14 indexed citations
17.
Fox, Sue. (2000). Business Etiquette for Dummies. Medical Entomology and Zoology. 2 indexed citations
18.
Sanderson, H. M., Sue Fox, Richard Robbins, et al.. (1998). Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets. 9(3-4). 245–250. 23 indexed citations
19.
Fox, Sue, et al.. (1994). Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism. Immunohematology. 10(2). 51–54. 11 indexed citations
20.
Heptinstall, Stan, J. Bevan, S R Cockbill, et al.. (1981). Inhibition Of Thromboxane Synthesis And Of Arachidonate- Induced Platelet Behaviour In Platelets From Different Individuals. Thrombosis and Haemostasis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026